ArticleCureus2025
Association of Dyslipidemia With Dermatological Manifestations in Patients With Type 2 Diabetes Mellitus.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives Type 2 diabetes mellitus (T2DM) is frequently related with various cutaneous manifestations, which may be influenced by comorbid conditions such as dyslipidemia. Hence, this study compared the demographic to match clinical and dermatological profiles of T2DM patients with and without dyslipidemia. Methodology This cross-sectional study was conducted at a secondary care hospital using a non-probability convenient sampling technique over six months. A total of 280 T2DM patients aged 40-65 years were included in this study. Patients were distributed into two equal groups: Group A (with dyslipidemia) and Group B (without dyslipidemia). Data on demographics, clinical history, lifestyle factors, treatment regimens, and dermatological findings were collected using structured questionnaires, physical examinations, and laboratory tests. A Chi-square test and a Mann-Whitney test were applied to examine the association of dermatological symptoms in T2DM. A p-value < 0.05 was reflected as statistically significant. Results The study findings showed that a significant gender disparity was observed: all patients in Group A were male subjects at 140 (100%), while Group B were predominantly female subjects at 88.6% (p<0.001). A larger proportion of Group A had diabetes for more than five years, 47 (33.6%) compared to Group B at 14 (10.0%), (p<0.001), and more frequent use of insulin and oral hypoglycemic agents (p=0.001). Xerosis with fissured skin was significantly more common in Group B at 109(77.9%), (p<0.001). The presence of bullae was also significantly greater in Group B at 54(38.6%) as compared to Group A at 25 (17.9%) (p<0.001). Although acanthosis nigricans showed no significant difference, it was slightly more prevalent in Group B. Conclusion This study concluded that the dermatological manifestations were common among T2DM patients, with notable differences based on dyslipidemia status. Patients without dyslipidemia showed a higher prevalence of xerosis, ichthyosis, callosities, and bullae, whereas paresthesias were more frequently observed in those with dyslipidemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.